Background: Hyperresponsiveness to histamine is a key feature of a variety of pathological conditions, including bronchial asthma, food allergy, colitis ulcerosa, and topical allergic disorders. Cells isolated from hyperresponsive individuals do not display exaggerated histamine responses ex vivo and thus the molecular mechanisms underlying histamine responsiveness remain obscure. Importantly, several in vivo observations implicate cysteinyl leukotrienes as possible mediators of increased histamine responses. We decided to investigate whether cysteinyl leukotrienes enhance the cellular reaction to histamine in cell types involved in pathological and immunological histamine hyperresponsiveness, as this might provide an in vitro system for studying histamine responsiveness and could shed light on the underlying molecular mechanisms.
Introduction
Histamine, which is produced by decarboxylation of the amino acid L-histidine (1) , is found in most tissues, mainly in the granules of mast cells, although numerous other cell types are capable of histamine synthesis as well (2) .
Histamine controls a large number of physiological functions by stimulating specific receptors on target cells. On the basis of their sensitivity to specific antagonists and agonists, three types of receptors for histamine have been characterized and named: the histamine receptor H1, H2, and H3 (3) . In general, activation of the H3 receptor is associated with autoinhibition of histamine production and release, stimulation of the H2 receptor is associated with gastric acid release, and the H1 receptor is implicated in inflammation, mediating, for instance, bronchial constriction, vascular permeabilization, and synthesis of other inflammatory agents (4) .
Exaggerated cellular histamine reactivity is associated with a variety of pathological conditions, in particular, asthmatic disease and other allergic disorders (5) . The molecular details underlying the enhanced histamine reactivity remain obscure (6) . Cells isolated from histamine hyperresponsive patients do not display exaggerated histamine responses ex vivo, and therefore factors present in the patient probably mediate hyperresponsiveness. Several possible mediators for histamine hyperreactivity have been described, including the cysteinyl leukotrienes (7, 8) . In 1983 Griffin (9) suggested that these inflammatory mediators are capable of inducing enhanced histamine reactivity. In agreement with this notion, it was demonstrated shortly afterward that cysteinyl leukotrienes cause fast and transient histamine hypersensitivity in guinea pig tracheal smooth muscle and airways (10, 11) and that inhalation challenge with cysteinyl leukotrienes produces hyperreactivity to histamine in human subjects (12, 13) . Furthermore, we recently demonstrated that in F9 embryonic carcinoma cells, histamine responses are strongly enhanced by prior application of leukotriene D4 (LTD4) or leukotriene E4 (LTE4) (6) . Therefore, cysteinyl leukotrienes appear to be capable of increasing histamine responsiveness both in vitro and in vivo, and in vitro stimulation of cells with these inflammatory lipids might provide a model system for studying histamine hyperreactivity.
These considerations prompted us to test the effect of cysteinyl leukotrienes on histamine responses of cells associated with histamine reactivity in vivo. Here we report that LTD4 and LTE4 enhance histamine-induced prostaglandin E2 (PGE2) production in immortalized mouse macrophages as (15) . It appeared that histamine caused a small, but statistically significant, increase in PGE2 production in primary isolated human umbilical smooth muscle cells (Fig. IA) , immortalized 4/4 murine macrophages (Fig. IB) , and freshly isolated human monocytes (Fig. 1C) . In the latter cell type, however, high histamine concentrations were not as effective as lower concentrations in stimulating PGE2 production. Addition of 100 ng/ml LTD4 or LTE4 to these cell types was also capable of inducing a modest, but statistically significant, stimulation of PGE2 synthesis highly comparable to that observed with histamine. Addition of either LTD4 or LTE4 together with histamine, however, strongly enhanced prostaglandin E2 release in both smooth muscle cells and macrophages, as well as monocytes (Fig. lA-C as well as primary isolated human monocytes, a 5-min incubation with LTE4 already produces a strong increase in histamine receptor number. In mouse macrophages, at later time points even more histamine receptors were detected, a maximum effect being reached at 15 min, after which receptor numbers declined again, although an increase above the control level was still detected 1 hr post-stimulation (Fig. 5) . In human monocytes, maximal induction of histamine receptors was observed 5 min after application of LTE4, whereas at later time points, the number of receptors gradually declined (Fig. 6 ). These results demonstrate, therefore, that the cysteinyl leukotriene-induced increase in histamine H1 receptor number is extremely fast, and of a transient nature.
Discussion
Histamine reactivity is under dynamic control and exaggerated histamine responses have been implicated in a variety of pathological conditions. The molecular mechanisms regulating histamine responsiveness are poorly understood. Strikingly, cells isolated from patients exhibiting clinical histamine hyperreactivity do not display such histamine hyperreactivity in vitro (16) (17) (18) (19) , demonstrating that factors present in the patient (13) , therefore, the effects observed in the present study cannot be directly extrapolated to the asthmatic patient. As histamine receptor activation is in itself a potent inducer of leukotriene synthesis, positive feedback may partly explain the discrepancy between the effects observed in vitro and in vivo. Furthermore, in vivo production of other secondary mediators (cytokines, interleukins, etc.) clearly influences histamine hyperreactivity (1 5) . Therefore, studies investigating cysteinyl leukotriene-induced histamine receptor unmasking in cells obtained in patients suffering from histamine hypersensitivity are needed to establish whether the enhancement of histamine receptor numbers observed in vitro may also be relevant in pathophysiology. Studies addressing this problem are currently in progress.
